Suheung Capsul (KO:008490) — Market Cap & Net Worth
Market Cap & Net Worth: Suheung Capsul (008490)
Suheung Capsul (KO:008490) has a market capitalization of $151.84 Million (₩224.05 Billion) as of September 17, 2026. Listed on the KO stock exchange, this Korea-based company holds position #17691 globally and #732 in its home market, demonstrating a -5.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Suheung Capsul's stock price ₩20150.00 by its total outstanding shares 11119113 (11.12 Million). Also see 008490 asset base for a full breakdown of the balance sheet.
Suheung Capsul Market Cap History: 2015 to 2026
Suheung Capsul's market capitalization history from 2015 to 2026. Data shows change from $296.06 Million to $151.84 Million (-6.95% CAGR). Also see Suheung Capsul cash flow conversion for how efficiently the company converts equity into cash flow.
Suheung Capsul Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Suheung Capsul's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Suheung Capsul (008490) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Suheung Capsul's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Suheung Capsul's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $261.43 Million | $340.36 Billion | $27.31 Billion | 0.00x | 0.01x |
| 2017 | $232.29 Million | $350.01 Billion | $23.08 Billion | 0.00x | 0.01x |
| 2018 | $168.76 Million | $393.48 Billion | $25.74 Billion | 0.00x | 0.01x |
| 2019 | $258.98 Million | $460.73 Billion | $31.72 Billion | 0.00x | 0.01x |
| 2020 | $375.45 Million | $553.01 Billion | $53.00 Billion | 0.00x | 0.01x |
| 2021 | $329.15 Million | $596.73 Billion | $53.69 Billion | 0.00x | 0.01x |
| 2022 | $253.56 Million | $634.97 Billion | $33.98 Billion | 0.00x | 0.01x |
| 2023 | $216.26 Million | $594.57 Billion | $6.12 Billion | 0.00x | 0.04x |
| 2024 | $95.62 Million | $653.26 Billion | $18.28 Billion | 0.00x | 0.01x |
| 2025 | $163.14 Million | $722.31 Billion | $43.49 Billion | 0.00x | 0.00x |
Competitor Companies of 008490 by Market Capitalization
Companies near Suheung Capsul in the global market cap rankings as of September 17, 2026. Review 008490 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Suheung Capsul by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Suheung Capsul Historical Marketcap From 2015 to 2026
Between 2015 and today, Suheung Capsul's market cap moved from $296.06 Million to $ 151.84 Million, with a yearly change of -6.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩151.84 Million | -6.93% |
| 2025 | ₩163.14 Million | +70.61% |
| 2024 | ₩95.62 Million | -55.78% |
| 2023 | ₩216.26 Million | -14.71% |
| 2022 | ₩253.56 Million | -22.97% |
| 2021 | ₩329.15 Million | -12.33% |
| 2020 | ₩375.45 Million | +44.97% |
| 2019 | ₩258.98 Million | +53.46% |
| 2018 | ₩168.76 Million | -27.35% |
| 2017 | ₩232.29 Million | -11.15% |
| 2016 | ₩261.43 Million | -11.70% |
| 2015 | ₩296.06 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Suheung Capsul was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $151.84 Million USD |
| MoneyControl | $151.84 Million USD |
| MarketWatch | $151.84 Million USD |
| marketcap.company | $151.84 Million USD |
| Reuters | $151.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Suheung Capsul
Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver… Read more